These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1194 related items for PubMed ID: 17668556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
    Netter HJ, Macnaughton TB, Woo WP, Tindle R, Gowans EJ.
    J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 4. Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix.
    Cheong WS, Drummer HE, Netter HJ.
    J Virol Methods; 2009 Jun; 158(1-2):35-40. PubMed ID: 19189849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 7. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M, Ahmed M, Zhou YH, Takahashi H, Shikata T.
    Virology; 1998 Nov 10; 251(1):158-64. PubMed ID: 9813211
    [Abstract] [Full Text] [Related]

  • 8. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E, Patient R, Hourioux C, Dimier-Poisson I, Roingeard P.
    Hepatology; 2013 Apr 10; 57(4):1303-13. PubMed ID: 23150224
    [Abstract] [Full Text] [Related]

  • 9. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadière B, Dalba C, Klatzmann D, Bellier B.
    Vaccine; 2013 Mar 01; 31(11):1540-7. PubMed ID: 22634300
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 11. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
    Lee IH, Kim CH, Ryu WS.
    J Med Virol; 1996 Oct 18; 50(2):145-51. PubMed ID: 8915880
    [Abstract] [Full Text] [Related]

  • 12. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 13. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
    Zheng X, Schirmbeck R, Hilken G, Waters JA, Yang D, Reimann J, Roggendorf M, Lu M.
    Virology; 2002 Mar 15; 294(2):342-53. PubMed ID: 12009876
    [Abstract] [Full Text] [Related]

  • 14. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
    Siler CA, McGettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ.
    Virology; 2002 Jan 05; 292(1):24-34. PubMed ID: 11878905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW.
    J Virol; 2006 Apr 05; 80(8):3975-84. PubMed ID: 16571814
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 derived peptides fused to HBsAg affect its immunogenicity.
    Gonzalez MC, Kostrzak A, Guetard D, Pniewski T, Sala M.
    Virus Res; 2009 Dec 05; 146(1-2):107-14. PubMed ID: 19766153
    [Abstract] [Full Text] [Related]

  • 18. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH, Yin W, An QX, Lei YF, Hu XB, Yang J, Lu X, Zhang H, Xu ZK.
    Arch Virol; 2008 Dec 05; 153(6):1021-9. PubMed ID: 18421415
    [Abstract] [Full Text] [Related]

  • 19. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.
    Vaccine; 2011 May 09; 29(20):3714-23. PubMed ID: 21396407
    [Abstract] [Full Text] [Related]

  • 20. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM, Logan M, Wong J, Kundu J, Hockman D, Landi A, Chen C, Crawford K, Wininger M, Johnson J, Mesa Prince C, Dudek E, Mehta N, Tyrrell DL, Houghton M.
    J Virol; 2018 Jun 01; 92(11):. PubMed ID: 29540595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.